- change ups
Items Tagged with 'pharmaceauticals'
NextWave makes the new ADHD drug Quillivant XR.
Global pharmaceutical maker Pfizer has announced its intention to acquire NextWave Pharmaceuticals of Cupertino, Calif., developer of Quillivant XR, the first once-daily liquid medication approved in the U.S. for the treatment of ADHD. Quillivant XR received approval from the U.S. Food and Drug Administration on Sept. 27, and it is expected to be in U.S. pharmacies in January. Read More